Cargando…
Dual Size/Charge‐Switchable Nanocatalytic Medicine for Deep Tumor Therapy
Elevating intratumoral levels of highly toxic reactive oxygen species (ROS) by nanocatalytic medicine for tumor‐specific therapy without using conventional toxic chemodrugs is recently of considerable interest, which, however, still suffers from less satisfactory therapeutic efficacy due to the rela...
Autores principales: | Wu, Wencheng, Pu, Yinying, Shi, Jianlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097343/ https://www.ncbi.nlm.nih.gov/pubmed/33977044 http://dx.doi.org/10.1002/advs.202002816 |
Ejemplares similares
-
Bacterial Metabolism-Initiated Nanocatalytic Tumor Immunotherapy
por: Wu, Wencheng, et al.
Publicado: (2022) -
Charge and Size Dual Switchable Nanocage for Novel Triple‐Interlocked Combination Therapy Pattern
por: Yang, Rui, et al.
Publicado: (2020) -
Nanocatalytic Tumor Therapy by Biomimetic Dual Inorganic Nanozyme‐Catalyzed Cascade Reaction
por: Gao, Shanshan, et al.
Publicado: (2018) -
Nanocatalytic bacteria disintegration reverses immunosuppression of colorectal cancer
por: Jiang, Han, et al.
Publicado: (2022) -
A nonferrous ferroptosis-like strategy for antioxidant inhibition–synergized nanocatalytic tumor therapeutics
por: Wu, Chenyao, et al.
Publicado: (2021)